Diligence memo · auto-generated · as of July 2, 2026
BroadOak Biolog, LLC
BroadOak Biolog, LLC looks fair against its niche peers and is active on financing cadence.
Businessfiled
BroadOak Biolog, LLC operates in Biotech / Pharma, based in BETHESDA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BroadOak Biolog, LLC has raised $5.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.0M on 2025-01-31.
Most recent recorded round closed around 2025-01-31.
Valuation (modeled)modeled
Provath models BroadOak Biolog, LLC at approximately $20M (range $5.6M–$37M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.17× the median modeled value of Series A Biotech / Pharma companies in 2025–2027 (16 peers) — value vs value, same stage and era. Within the normal band (117% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 17 mo ago; this sector typically re-raises about every 15 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 50% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 43% of those peers.
Closest niche peers: Evio Pharmacy Solutions, LLC, Ruby Bio, Inc., Intelligent Bio Solutions Inc., Barnwell Bio, Inc., Arkea Bio Corp..
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.